Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02348281
Recruitment Status : Terminated (it's too slow to enroll suitable patients into this study)
First Posted : January 28, 2015
Last Update Posted : January 23, 2018
Sponsor:
Information provided by (Responsible Party):
Xichun Hu, Fudan University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2015
  Actual Study Completion Date : December 2015